Dronedarone and Captisol-enabled Amiodarone in an Experimental Cardiac Arrest

被引:4
|
作者
Glover, Benedict M. [1 ,2 ]
Hu, Xudong [1 ,2 ]
Aves, Theresa [1 ,2 ]
Ramadeen, Andrew [1 ,2 ]
Zou, Lily [1 ,2 ]
Leong-Poi, Howard [1 ,2 ]
Fujii, Hiroko [1 ,2 ]
Dorian, Paul [1 ,2 ]
机构
[1] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada
[2] Univ Toronto, Dept Med, Toronto, ON, Canada
关键词
dronedarone; nexterone; cardiac arrest; drug therapy; VENTRICULAR-TACHYCARDIA; INTRAVENOUS AMIODARONE; ATRIAL-FIBRILLATION; HEART-FAILURE; ARRHYTHMIAS; RECURRENT; ISCHEMIA; SR-33589; RESUSCITATION; REPERFUSION;
D O I
10.1097/FJC.0b013e3182868750
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To compare the energy required for defibrillation and postshock outcomes after the administration of dronedarone, amiodarone, and placebo in a porcine model of cardiac arrest. Methods: Forty-two pigs were randomized to amiodarone, dronedarone, or control treatments. After induction of ventricular fibrillation, compressions and ventilations were performed for 3 minutes and treatment was administered over 30 seconds. If defibrillation was unsuccessful, cardiopulmonary resuscitation continued and repeated shocks were administered every 2 minutes with continual hemodynamic monitoring for a total duration of 30 minutes. Results: The cumulative energy required for defibrillation was 570 +/- 422 J for dronedarone, 441 +/- 365 J for amiodarone, and 347 +/- 281 J for control (P = not significant). Survival at 30 minutes was 1 (7.1%) for dronedarone compared with 11 (78.6%) for control (P = 0.001). Mortality in the dronedarone group was because of refibrillation in 3 (21.4%) cases, atrioventricular block in 1 (7.1%) case, and hypotension not because of bradycardia in 9 (64.3%) cases. Two minutes after successful defibrillation, systolic aortic pressure was lower in dronedarone versus control (86.6 +/- 26.9 vs. 110 +/- 15.1 mm Hg; P = 0.035). Conclusions: The administration of dronedarone resulted in a significant reduction in survival and both systolic aortic and coronary perfusion pressure compared with control.
引用
收藏
页码:385 / 390
页数:6
相关论文
共 50 条
  • [31] Comparison of use and role of adrenaline and amiodarone in cardiac arrest: Case of emergency center in Kosovo
    Lenjani, Basri
    Baftiu, Nehat
    Bunjaku, Ilaz
    Hyseni, Kadir
    Jakupi, Arianit
    JOURNAL OF ACUTE DISEASE, 2013, 2 (02) : 106 - 108
  • [32] Prolonged cardiac arrest and resuscitation by extracorporeal life support: favourable outcome without preceding anticoagulation in an experimental setting
    Foerster, K.
    D'Inka, M.
    Beyersdorf, F.
    Benk, C.
    Nguyen-Thanh, T.
    Mader, I.
    Fritsch, B.
    Ihling, C.
    Mueller, K.
    Heilmann, C.
    Trummer, G.
    PERFUSION-UK, 2013, 28 (06): : 520 - 528
  • [33] Survival After Intravenous Versus Intraosseous Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Shock-Refractory Cardiac Arrest
    Daya, Mohamud R.
    Leroux, Brian G.
    Dorian, Paul
    Rea, Thomas D.
    Newgard, Craig D.
    Morrison, Laurie J.
    Lupton, Joshua R.
    Menegazzi, James J.
    Ornato, Joseph P.
    Sopko, George
    Christenson, Jim
    Idris, Ahamed
    Mody, Purav
    Vilke, Gary M.
    Herdeman, Caroline
    Barbic, David
    Kudenchuk, Peter J.
    CIRCULATION, 2020, 141 (03) : 188 - 198
  • [34] Comparison of the Effects of Lidocaine and Amiodarone on Patients With Cardiac Arrest: A Systematic Review and Meta-Analysis
    Sinha, Tanya
    Reyaz, Ibrahim
    Ibrahim, Roba A.
    Guntha, Manisha
    Zin, Aung K.
    Chapala, Grahitha
    Ravuri, Mohan K.
    Palleti, Sujith K.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [35] Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The ALPS Study (Amiodarone, Lidocaine, or Placebo)
    Kudenchuk, Peter J.
    Leroux, Brian G.
    Daya, Mohamud
    Rea, Thomas
    Vaillancourt, Christian
    Morrison, Laurie J.
    Callaway, Clifton W.
    Christenson, James
    Ornato, Joseph P.
    Dunford, James V.
    Wittwer, Lynn
    Weisfeldt, Myron L.
    Aufderheide, Tom P.
    Vilke, Gary M.
    Idris, Ahamed H.
    Stiell, Ian G.
    Colella, M. Riccardo
    Kayea, Tami
    Egan, Debra
    Desvigne-Nickens, Patrice
    Gray, Pamela
    Gray, Randal
    Straight, Ron
    Dorian, Paul
    CIRCULATION, 2017, 136 (22) : 2119 - 2131
  • [36] Mechanistic characterization of nitrite-mediated neuroprotection after experimental cardiac arrest
    Dezfulian, Cameron
    Kenny, Elizabeth
    Lamade, Andrew
    Misse, Amalea
    Krehel, Nicholas
    St Croix, Claudette
    Kelley, Eric E.
    Jackson, Travis C.
    Uray, Thomas
    Rackley, Justin
    Kochanek, Patrick M.
    Clark, Robert S. B.
    Bayir, Hulya
    JOURNAL OF NEUROCHEMISTRY, 2016, 139 (03) : 419 - 431
  • [37] Neither vasopressin nor amiodarone improve CPR outcome in an animal model of hypothermic cardiac arrest
    Schwarz, B
    Mair, P
    Wagner-Berger, H
    Stadlbauer, KH
    Girg, S
    Wenzel, V
    Lindner, KH
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2003, 47 (09) : 1114 - 1118
  • [38] Early amiodarone or lidocaine administration during in-hospital cardiac arrest caused by shockable rhythms
    Paganoni, Rafael C.
    Pluenneke, Jack C.
    Mohamed, Adham M.
    Hayes, Charles H.
    Freiberger-O'Keefe, Carole E.
    Chan, Paul S.
    RESUSCITATION PLUS, 2025, 22
  • [39] MYELIN-OLIGODENDROGLIA COMPLEX IN RATS SUBJECTED TO EXPERIMENTAL CARDIAC-ARREST
    WENDER, M
    SZCZECH, J
    EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 1994, 46 (06) : 477 - 481
  • [40] Lidocaine Versus Amiodarone For Pediatric In-hospital Cardiac Arrest With A Shockable Rhythm: An Observational Study
    Holmberg, Mathias Johan
    Ross, Catherine E.
    Atkins, Dianne L.
    Valdes, Santiago O.
    Donnino, Michael
    Andersen, Lars W.
    CIRCULATION, 2019, 140 (25) : E1009 - E1010